Literature DB >> 23055086

Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury.

Jian-Ming Li1, Zhi-Qin Xue, Si-Hao Deng, Xue-Gang Luo, Peter R Patrylo, Gregory W Rose, Huaibin Cai, Yan Cai, Xiao-Xin Yan.   

Abstract

The spinal cord is composed of distinct neuronal groups with well-defined anatomic connections. In some transgenic (Tg) models of Alzheimer's disease (AD), amyloid plaques develop in this structure, although the underlying cellular mechanism remains elusive. We attempted to explore the origin, evolution, and modulation of spinal β-amyloid (Aβ) deposition using Tg mice harboring five familiar AD-related mutations (5XFAD) as an experiential model. Dystrophic neuritic elements with enhanced β-secretase-1 (BACE1) immunoreactivity (IR) appeared as early as 2 months of age, and increased with age up to 12 months examined in this study, mostly over the ventral horn (VH). Extracellular Aβ IR emerged and developed during this same period, site-specifically co-existing with BACE1-labeled neurites often in the vicinity of large VH neurons that expressed the mutant human APP. The BACE1-labeled neurites almost invariably colocalized with β-amyloid precursor protein (APP) and synaptophysin, and frequently with the vesicular glutamate transporter-1 (VGLUT). Reduced IR for the neuronal-specific nuclear antigen (NeuN) occurred in the VH by 12 months of age. In 8-month-old animals surviving 6 months after a unilateral sciatic nerve transection, there were significant increases of Aβ, BACE1, and VGLUT IR in the VN of the ipsilateral relative to contralateral lumbar spinal segments. These results suggest that extracellular Aβ deposition in 5XFAD mouse spinal cord relates to a progressive and amyloidogenic synaptic pathology largely involving presynaptic axon terminals from projection neurons in the brain. Spinal neuritic plaque formation is enhanced after peripheral axotomy, suggesting a retrograde transneuronal modulation on pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055086      PMCID: PMC3563929          DOI: 10.1007/s12640-012-9355-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  61 in total

1.  Age-dependent axonal degeneration in an Alzheimer mouse model.

Authors:  Oliver Wirths; Joachim Weis; Rakez Kayed; Takaomi C Saido; Thomas A Bayer
Journal:  Neurobiol Aging       Date:  2006-09-11       Impact factor: 4.673

Review 2.  Mechanisms of amyloid plaque pathogenesis.

Authors:  John C Fiala
Journal:  Acta Neuropathol       Date:  2007-09-06       Impact factor: 17.088

3.  Expression of the vesicular glutamate transporters-1 and -2 in adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury.

Authors:  P Brumovsky; M Watanabe; T Hökfelt
Journal:  Neuroscience       Date:  2007-06-29       Impact factor: 3.590

4.  Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease.

Authors:  Yasuaki Goto; Tetsuhiro Niidome; Haruyuki Hongo; Akinori Akaike; Takeshi Kihara; Hachiro Sugimoto
Journal:  Eur J Pharmacol       Date:  2008-02-05       Impact factor: 4.432

Review 5.  The many faces of amyloid beta in Alzheimer's disease.

Authors:  Peter K Chiang; Michael A Lam; Yuan Luo
Journal:  Curr Mol Med       Date:  2008-09       Impact factor: 2.222

Review 6.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

7.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

8.  Ten-year change in plasma amyloid beta levels and late-life cognitive decline.

Authors:  Olivia I Okereke; Weiming Xia; Dennis J Selkoe; Francine Grodstein
Journal:  Arch Neurol       Date:  2009-10

Review 9.  Reassessing the amyloid cascade hypothesis of Alzheimer's disease.

Authors:  Sanjay W Pimplikar
Journal:  Int J Biochem Cell Biol       Date:  2008-12-30       Impact factor: 5.085

10.  Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina.

Authors:  Kun Xiong; Huaibin Cai; Xue-Gang Luo; Robert G Struble; Richard W Clough; Xiao-Xin Yan
Journal:  Exp Brain Res       Date:  2007-04-12       Impact factor: 1.972

View more
  8 in total

1.  Lipolysaccharide-Induced Neuroinflammation Is Associated with Alzheimer-Like Amyloidogenic Axonal Pathology and Dendritic Degeneration in Rats.

Authors:  Xiaohua Deng; Meili Li; Weiming Ai; Lixin He; Dahua Lu; Peter R Patrylo; Huaibin Cai; Xuegang Luo; Zhiyuan Li; Xiaoxin Yan
Journal:  Adv Alzheimer Dis       Date:  2014-06

Review 2.  Can BACE1 inhibition mitigate early axonal pathology in neurological diseases?

Authors:  Xiao-Xin Yan; Chao Ma; Wei-Ping Gai; Huaibin Cai; Xue-Gang Luo
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Intracerebral Injection of Metal-Binding Domain of Aβ Comprising the Isomerized Asp7 Increases the Amyloid Burden in Transgenic Mice.

Authors:  Alexandra A Kulikova; Ivan B Cheglakov; Michail S Kukharsky; Ruslan K Ovchinnikov; Sergey A Kozin; Alexander A Makarov
Journal:  Neurotox Res       Date:  2016-02-03       Impact factor: 3.911

4.  Inverse correlation between Alzheimer's disease and cancer: implication for a strong impact of regenerative propensity on neurodegeneration?

Authors:  Jian-Ming Li; Chao Liu; Xia Hu; Yan Cai; Chao Ma; Xue-Gang Luo; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2014-11-14       Impact factor: 2.474

Review 5.  The Ubiquitin-Proteasome System: Potential Therapeutic Targets for Alzheimer's Disease and Spinal Cord Injury.

Authors:  Bing Gong; Miroslav Radulovic; Maria E Figueiredo-Pereira; Christopher Cardozo
Journal:  Front Mol Neurosci       Date:  2016-01-26       Impact factor: 5.639

6.  Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine?

Authors:  Jian-Ming Li; Li-Ling Huang; Fei Liu; Bei-Sha Tang; Xiao-Xin Yan
Journal:  BMC Neurol       Date:  2017-08-25       Impact factor: 2.474

7.  Axonal and myelinic pathology in 5xFAD Alzheimer's mouse spinal cord.

Authors:  Tak-Ho Chu; Karen Cummins; Joseph S Sparling; Shigeki Tsutsui; Craig Brideau; K Peter R Nilsson; Jeffrey T Joseph; Peter K Stys
Journal:  PLoS One       Date:  2017-11-27       Impact factor: 3.240

8.  Comparisons of neuroinflammation, microglial activation, and degeneration of the locus coeruleus-norepinephrine system in APP/PS1 and aging mice.

Authors:  Song Cao; Daniel W Fisher; Guadalupe Rodriguez; Tian Yu; Hongxin Dong
Journal:  J Neuroinflammation       Date:  2021-01-06       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.